CRH Medical - CRHM Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.99
+0 (0.00%)

This chart shows the closing price for CRHM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CRH Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRHM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRHM

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for CRH Medical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $3.99.

This chart shows the closing price for CRHM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in CRH Medical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/31/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/9/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
2/9/2021National Bank FinancialDowngradeOutperform
1/8/2021Bloom BurtonDowngradeHold$3.00
12/23/2020Bloom BurtonDowngradeBuy ➝ Hold
11/24/2020Acumen CapitalReiterated RatingBuy$6.00
8/13/2020Bloom BurtonReiterated RatingBuy$4.00
8/12/2020Bloom BurtonReiterated RatingBuy
8/12/2020Royal Bank of CanadaBoost TargetOutperform$4.00 ➝ $4.50
5/14/2020Beacon SecuritiesDowngradeBuy ➝ Hold
5/14/2020Royal Bank of CanadaLower TargetOutperform$4.75 ➝ $4.00
3/13/2020Royal Bank of CanadaLower TargetOutperform$6.50 ➝ $4.75
(Data available from 12/26/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
CRH Medical logo
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 70 ambulatory surgical/endoscopy centers in 14 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $3.99
Low: $3.99
High: $4.00

50 Day Range

MA: N/A

52 Week Range

Now: $3.99
Low: $1.66
High: $4.01

Volume

388,400 shs

Average Volume

1,043,867 shs

Market Capitalization

$285.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.41

Frequently Asked Questions

What sell-side analysts currently cover shares of CRH Medical?

The following equities research analysts have issued stock ratings on CRH Medical in the last twelve months:
View the latest analyst ratings for CRHM.

What is the current price target for CRH Medical?

0 Wall Street analysts have set twelve-month price targets for CRH Medical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for CRH Medical in the next year.
View the latest price targets for CRHM.

What is the current consensus analyst rating for CRH Medical?

CRH Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CRHM.

What other companies compete with CRH Medical?

How do I contact CRH Medical's investor relations team?

CRH Medical's physical mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company's listed phone number is +1-604-6331440 and its investor relations email address is [email protected]. The official website for CRH Medical is investors.crhsystem.com. Learn More about contacing CRH Medical investor relations.